Announcements

Removal of Component(s) – PNT, ICPT

November 3, 2023

LifeSci Biotechnology Clinical Trials Index

LifeSci Biotechnology Products Index

Effective at the market close on Monday, November 6, 2023, the following changes will be made the LifeSci Biotechnology Indexes:

PNT will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights.

On October 3, 2023, Point Biopharma Global announced it would be acquired by Eli Lilly and Company for $12.50/share in cash.

ICPT will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.

On September 26, 2023, Intercept Pharmaceuticals announced that it would be acquired by Alfasigma for $19.00/share in cash.